Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: 10-Q delayed

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

gcduck

Rank: President [?]

Points: 12254 [?]

Votes: 135 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: 10-Q delayed - @biaji:

in response to

Re: 10-Q delayed. "beyond expectations" Unfortunately,

biajj

posted on Jan 10, 2011 06:32PM

"The negotiations discussions seem like old news that has already been disclosed, so for whatever reason, that application explaination seems odd to me."

It's not surprising you only see the negatives in this postponement but if you have business experience you know how difficult negotiation talks can be - so a delay is normal procedure.

And of course a settlement with TPL (which I guess is be the reason for the shift) would be THE MATERIAL EVENT we all are eagerly waiting for, so what else should the management do in your opinion rather then postpone the 10Q until they might achieve a result?